POAIPredictive OncologyPOAI info
$0.69info-3.77%24h
Global rank33448
Market cap$2.80M
Change 7d-13.75%
YTD Performance-78.77%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Predictive Oncology (POAI) Stock Overview

    Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

    POAI Stock Information

    Symbol
    POAI
    Address
    2915 Commers DriveEagan, MN 55121United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.predictive-oncology.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    651 389 4800

    Predictive Oncology (POAI) Price Chart

    -
    Value:-

    Predictive Oncology Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.69
    N/A
    Market Cap
    $2.80M
    N/A
    Shares Outstanding
    4.06M
    N/A
    Employees
    31.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org